Anbio Biotechnology (NNNN) — 6-K Filings

All 6-K filings from Anbio Biotechnology. Browse 3 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (3)

  • Anbio Biotechnology Reports H1 2025 Financials — Dec 30, 2025 Risk: low
    Anbio Biotechnology, a Cayman Islands exempted company, announced its unaudited financial results for the six months ended June 30, 2025, via a press release on
  • 6-K Filing — Nov 13, 2025
  • Anbio Biotechnology Announces IPO Details — Feb 21, 2025 Risk: medium
    Anbio Biotechnology, a Cayman Islands exempted company, announced on February 18, 2025, its initial public offering (IPO). The company agreed to sell 1,600,000

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.